Sandoz Group AG (SDZ.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH1243598427
Sandoz Group AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 10.38 bn USD | 11.16 bn USD |
| Gross profit | 5.02 bn USD | 5.28 bn USD |
| Operating income | 293.00 m USD | 1.43 bn USD |
| EBIT | 1.59 bn USD | – |
| Net income | 0.00 USD | 957.48 m USD |
| Diluted EPS – continuing operations | 0.00 USD | 2.09 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
More stocks
- Asia Vital Components Co Ltd (3017.TW)
- Waste Connections, Inc. (WCN)
- Investview, Inc. (INVUP)
- Prudential Financial (PRU)
- Live Nation Entertainment (LYV)
- Paychex (PAYX)
- Sun Hung Kai Properties Ltd (16.HK)
- Sysco (SYY)
- Microchip Technology (MCHP)
- Assa Abloy AB (ASSA B.ST)
- HDFC Bank Limited ADR (HDB)
- Chipotle Mexican Grill (CMG)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.